methoxamine
| SMILES | COc1ccc(c(c1)C(C(N)C)O)OC |
| InChIKey | WJAJPNHVVFWKKL-UHFFFAOYSA-N |
Chemical properties
| Hydrogen bond acceptors | 4 |
| Hydrogen bond donors | 2 |
| Rotatable bonds | 4 |
| Molecular weight (Da) | 211.1 |
Drug properties
| Molecular type | Small molecule |
| Physiological/Surrogate | Surrogate |
| Approved drug | Yes |
Sankey plot
, 'sankey_.png');){kind=link}
, 'sankey_.jpg');){kind=link}
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| α1A | ADA1A | Human | Adrenoceptors | A | pKi | 4.6 | 4.9 | 5.2 | Guide to Pharmacology |
| α1B | ADA1B | Human | Adrenoceptors | A | pKi | 3.0 | 3.5 | 4.0 | Guide to Pharmacology |
| α1D | ADA1D | Human | Adrenoceptors | A | pKi | 3.8 | 4.35 | 4.9 | Guide to Pharmacology |
| α1D | ADA1D | Rat | Adrenoceptors | A | pKi | 4.5 | 4.5 | 4.5 | Guide to Pharmacology |
| α1B | ADA1B | Human | Adrenoceptors | A | pKi | 5.0 | 5.0 | 5.0 | PDSP Ki database |
| α1D | ADA1D | Rat | Adrenoceptors | A | pKi | 5.0 | 5.0 | 5.0 | PDSP Ki database |
| α1B | ADA1B | Rat | Adrenoceptors | A | pKi | 5.79 | 5.79 | 5.79 | PDSP Ki database |
| α1B | ADA1B | Human | Adrenoceptors | A | pKi | 8.4 | 8.4 | 8.4 | Drug Central |
| α1D | ADA1D | Rat | Adrenoceptors | A | pKi | 8.35 | 8.35 | 8.35 | Drug Central |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| α1A | ADA1A | Human | Adrenoceptors | A | pEC50 | 4.4 | 6.25 | 8.1 | Guide to Pharmacology |
| α1B | ADA1B | Human | Adrenoceptors | A | pEC50 | 4.0 | 5.3 | 6.6 | Guide to Pharmacology |
| α1D | ADA1D | Human | Adrenoceptors | A | pEC50 | 5.1 | 5.25 | 5.4 | Guide to Pharmacology |
| α1A | ADA1A | Human | Adrenoceptors | A | pEC50 | 6.14 | 6.14 | 6.14 | ChEMBL |
| α1A | ADA1A | Human | Adrenoceptors | A | pEC50 | 8.29 | 8.29 | 8.29 | Drug Central |
| α1D | ADA1D | Human | Adrenoceptors | A | pEC50 | 8.31 | 8.31 | 8.31 | Drug Central |